Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical insulin for oral lichen planus
IRCT20241208063991N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human insulin in oral lichen planus (OLP), sponsored by Tehran University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
human insulin
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20241208063991N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241208063991N1.